Arkolith/Insider Trading/PTCT/Form 4

Boulding Mark Elliott

EXEC. VP AND CLOPTC THERAPEUTICS, INC. (PTCT) · full profile →Form 4 · filed Apr 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$157K
Net Open-Market Flow
-$157K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 6, 2026Option exercise(M)2K$39.42$89K107K
Apr 6, 2026Sell(S)822$68.91$57K107K
Apr 6, 2026Sell(S)1K$69.75$101K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 6, 2026Option exercise(M)2K—$07K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001578852-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML